
Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
Keywords: اثربخشی هزینه; Knee osteoarthritis; Cost-effectiveness; Quality of life; Disease-modifying osteoarthritis drugs (DMOADs)